Codexis, Inc.

CDXS Healthcare Biotechnology

Codexis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.4 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 2.69%, EPS grew 18.8%, free cash flow grew 48.6% and total debt fell 14.1%, each against the same quarter a year earlier.

1.24 0.12 −8.82%
Market cap
$148.9M
P/E
0.0×
Fwd P/E
−6.6×
Dividend yield
—
F-score
4/9
Altman Z
−4.75
Beneish M
−3.57
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
96.82 98.77 93.47 162.89 161.89 184.42 114.21 68.20 45.04 27.23
Total non-current assets
50.98 50.24 43.10 87.50 84.50 37.22 34.87 11.09 8.59 8.42
Total Assets
147.80 149.01 136.56 250.39 246.38 221.65 149.07 79.28 53.63 35.65
Total current liabilities
25.32 23.65 35.83 49.07 33.37 24.98 15.39 18.11 24.95 12.37
Total non-current liabilities
71.95 58.44 14.12 56.53 48.62 26.56 28.17 4.86 4.13 4.18
Total liabilities
97.27 82.08 49.95 105.60 81.99 51.54 43.56 22.98 29.08 16.55
Common Equity (Total)
50.53 66.93 86.62 144.80 164.39 170.10 105.52 56.31 24.55 19.10
Shareholders Equity (Total)
50.53 66.93 86.62 144.80 164.39 170.10 105.52 56.31 24.55 19.10
Total Debt
40.11 28.91 — 38.28 43.56 22.32 24.95 0.10 0.76 0.89

Show all line items

In millions of $ except per-share values · columns are period end dates